Nefrología Vol. 32 Nº 1 Año 2012
Nefrologia (Madr.) 2012;32:89-93 | doi: 10.3265/Nefrologia.pre2011.Nov.10967

Efecto de la DDVAP intranasal en la prevención de la hipotensión durante la hemodiálisis

Effect of Intranasal DDAVP in Prevention of Hypotension during Hemodialysis


a Department of internal medicine, Faculty of Medicine, Jundishapur University of Medical Sciences, Ahvaz, Iran,
b Science and Research Branch, Department of Chemistry, Islamic Azad University, Omidiyeh, Iran,
Resumen
Abstract
Palabras Clave:
Ver / Descargar PDF
Referencias Bibliográficas
1.
Skroeder NR, Jacobson SH, Lins LE, Kjellstrand CM. Acute symptoms during and between hemodialysis: the relative role of speed, duration, and biocompatibility of dialysis. Artif Organs 1994;18:880. [Pubmed]
2.
Van der Sande FM, Kooman JP, Leunissen KM. Intradialytic hypotension--new concepts on an old problem. Nephrol Dial Transplant 2000;15:1746. [Pubmed]
3.
3. Milinkovic M, Zidverc-Trajkovic J, Sternic N, Trbojevic-Stankovic J, Maric I, Milic M, et al. Hemodialysis headache. Clin Nephrol 2009;71:158.
4.
Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, et al. "U" curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 1998;4:561-9.
5.
Shoji T, Tsubakihara Y, Fujii M, Imai E. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 2004;66:1212-20. [Pubmed]
6.
Dasselaar JJ, Huisman RM, de Jong PE, Franssen CF. Measurement of relative blood volume changes during haemodialysis: merits and limitations. Nephrol Dial Transplant  2005;20(10):2043-9. 
7.
Kooman J, Basci A, Pizzarelli F, Canaud B, Haage P, Fouque D, et al. EBPG guideline on haemodynamic instability. Nephrol Dial Transplant 2007;22 Suppl 2:ii22-44. [Pubmed]
8.
Dheenan S, Henrich WL. Preventing dialysis hypotension: a comparison of usual protective maneuvers. Kidney Int 2001;59(3):1175-81. [Pubmed]
9.
9. Daugirdas JT. Preventing and managing hypotension. Semin Dial 1994;7:276-83.
10.
10. Knoll GA, Grabowski JA, Dervin GF, O'Rourke K. A randomized, controlled trial of albumin versus saline for the treatment of intradialytic hypotension. J Am Soc Nephrol 2004;15(2):487-92. [Pubmed]
11.
11. Yu AW, Ing TS, Zabaneh RI, Jensen UB, Tryggvason K. Effect of dialysate temperature on central hemodynamics and urea kinetics. Kidney Int 1995;48:327-43.
12.
12. Prakash S, Garg AX, Heidenheim AP, House AA. Midodrine appears to be safe and effective for dialysis-induced hypotension: a systematic review. Nephrol Dial Transplant 2004;19:2553-8. [Pubmed]
13.
13. Moret K, Aalten J, Wall Bake W, Gerlag P, Beerenhout C, van der Sande F, et al. The effect of sodium profiling and feedback technologies on plasma conductivity and ionic mass balance: a study in hypotension-prone dialysis patients. Nephrol Dial Transplant 2006;21:138-44.  [Pubmed]
14.
14. Donauer J. Hemodialysis-induced hypotension: impact of technologic advances. Semin Dial 2004;17:333-5.
15.
Daugirdas JT. Pathophysiology of dialysis hypotension: an update. Am J Kidney Dis 2001;38(4 suppl 4):S11-7.
16.
16. Leunissen KM, Kooman JP, van Kuijk W, van der Sande F, Luik AJ, van Hooff JP. Preventing haemodynamic instability in patients at risk for intra-dialytic hypotension. Nephrol Dial Transplant 1996;11 Suppl 2:11-5. [Pubmed]
17.
17. Armengol NE CAA, Bono Illa M, Calls Ginesta J, Gaya Bertran J, Rivera Fillat DR. Vasoactive hormones in uraemic patients with chronic hypotension. Nephrol Dial Transplant 1997;12:321-4. [Pubmed]
18.
18. Shoji T, Tsubakihara Y, Fujii M, Imai E. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 2004;66:1212-20. [Pubmed]
19.
19. Friess U, Rascher W, Ritz E, Gross P. Failure of arginine-vasopressin and other pressor hormones to increase in severe recurrent dialysis hypotension. Nephrol Dial Transplant 1995;10:1421-7. [Pubmed]
20.
20.  Rho M, Perazella MA, Parikh CR, Peixoto AJ, Brewster UC. Serum Vasopressin Response in Patients with Intradialytic Hypotension: A Pilot Study. Clin J Am Soc Nephrol 2008;3(3):729-35. [Pubmed]
21.
21. Van der Zee S, Thompson A, Zimmerman R, Lin J, Huan Y, Braskett M, et al. Vasopressin administration facilitates fluid removal during hemodialysis. Kidney Int 2007;71:318-24. [Pubmed]
22.
22. Lindberg JS, Copley JB, Melton K, Wade CE, Abrams J, Goode D.  Lysine Vasopressin in the Treatment of Refractory Hemodialysis-Induced Hypotension. Am J Nephrol 1990;10:269-75. [Pubmed]
23.
23. Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest 2001;120:989-1002. [Pubmed]
24.
24. Sato K, Kimura T, Ota K, Shoji M, Ohta M, Yamamoto T, et al. Changes in plasma vasopressin levels and cardiovascular function due to postural changes in diabetic neuropathy. Tohoku J Exp Med 1995;177:49-60. [Pubmed]
25.
25. Cignarelli M, De Pergola G, Paternostro A, Corso M, Cospite MR, Centaro GM, et al. Arginine-vasopressin response to supine-erect posture change: an index for evaluation of the integrity of the afferent component of baroregulatory system in diabetic neuropathy. Diabete Metab 1986;12:28-33. [Pubmed]
Órgano Oficial de la Sociedad Española de Nefrología
Contactar | Web Map | Aviso legal